Amplify Weight Loss Drug & Treatment ETF (THNR) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $3.2M, listed on AMEX, carrying a beta of 0.41 to the broader market. THNR provides access to global companies expected to economically benefit from weight loss drug development. public since 2024-05-21.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for THNR as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →